Use of quinolizin- and quinolizinonderivater for the preparation of a medicinal product

摘要

The present invention is directed to the use of hetrocyclic esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines as cardiac antiarrhythmic agents.